XBiotech (XBIT) insider trading
Insider activity, historical context and SEC filings · data through Oct 28, 2026
Insiders put their own money in: $711K of open-market buys. See how similar setups did below.
Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Purchase John Simard, Director bought 368,524 shares at $1.93 ($711K).
- Trade date
- Oct 26, 2026
- Disclosed to the SEC
- Oct 28, 2026
- Type
- Open-market purchase (code P)
Read the original SEC filing ↗All XBIT insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
Similar past setups: not applicable. There aren't enough comparable past cases for XBIT's latest buying to report odds. When insiders buy, this section shows how 16,899 similar past buys did over 90 days. How we calculate this →
Play with XBIT in the Research Lab
Pre-set to XBIT's latest insider buy of $10K or more (Oct 28, 2026: John Simard, $711K). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 16,899 past insider buys did.
Share price and insider trades
Price history unavailable.
XBiotech insider trading at a glance (Oct 28, 2026): in the past 12 months, 1 insider bought $711K and 0 sold $0 of XBIT stock on the open market.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this
XBIT insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $711K | 1 | — | 0 |
Valuation, profit and volume
Valuation figures for XBIT are refreshed each weekday; some aren't published for every company. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 XBiotech Inc. insider reported open-market purchases totaling $711K, while 0 insiders reported sales totaling $0.
What happened after XBIT insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Oct 28, 2026 | John SimardDirector | $711K | pending | pending | pending |
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 28 NewSEC | John SimardDirector | Buy | 368,5244,191,690 held (+10%) | $1.93 | $711K | — | — |
Insiders at XBiotech Inc.
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| John SimardDirector | $711K | — | Oct 28, 2026 | — | — |
XBIT stock: common questions
Are XBiotech Inc. insiders buying XBIT stock?
In the past 12 months, 1 insiders reported open-market purchases of XBIT worth $711K. The latest was Director John Simard bought $711K of XBIT at $1.93 — first open-market purchase in our records.
Are XBiotech Inc. insiders selling XBIT stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.